INSIGHTS ON DRUG DEVELOPMENT
-
Technology-Led Expansion Of Oligonucleotide Capabilities
Advances in synthesis, enzymatic ligation, and purification are reshaping oligonucleotide manufacturing, improving scalability, sustainability, and complexity from research to production.
-
Epigenetics Application Guide
To fully understand biology and disease mechanisms, it is crucial to explore the role of epigenetic factors. Explore how epigenetic regulation works and methods to study these essential components.
-
Accelerating Method Development And Manufacturing Of GLP-1 Analogs
Explore a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.
-
Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook
View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.
-
Step-By-Step Guide To Tech Transfer Preparation And Execution10/31/2024
How does a sponsor accurately transfer detailed knowledge about its product composition, development, and current manufacturing processes to its CDMO?
-
Aggregate Analysis Of Tirzepatide12/11/2025
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Silencing CDMO Project Noise: The Power Of Low-Drama Drug Development3/3/2026
Move beyond reactive firefighting by prioritizing disciplined leadership and data-driven milestones. The winning model for complex programs is focused, high-maturity, low-drama execution.
-
Advancing Drug Development With Optimized LC-MS/MS Bioanalysis5/7/2025
Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.
-
Assessing Production And Stability Of Antibody Drug Conjugate Platforms9/24/2025
ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.
DRUG DEVELOPMENT SOLUTIONS
-
Highly potent APIs require stringent containment and precise manufacturing controls. Specialized facilities offer end-to-end development solutions and robust cross-contamination protections.
-
This device is designed for use with a wide range of drug therapies that require variable dosing.
-
Are you using obsolete or aging instruments simply because they continue to work? Running your laboratory with outdated technology brings about challenges beyond just headaches. Older technology may limit your performance, increase your costs, and open your lab up to risk. It may be time to investigate the real cost of using obsolete technology.
With the Waters FlexUP Technology Renewal Program, always work with the latest technology for optimum productivity and security.
-
Learn how peptide‑synthesis platforms, early impurity control, and optimized downstream methods boost scalability, stability, and development speed from early design to late‑stage readiness.
-
Whether you're looking to boost performance, enhance your capabilities, or simply get consistent, high-quality results, HyClone™ peak expression medium and HyClone™ prime expression medium are the solutions for you.